Revlimid and Shortness of breath - from FDA reports


Summary

Shortness of breath is found among people who take Revlimid, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Zometa, and have Myelodysplastic syndrome. This review analyzes which people have Shortness of breath with Revlimid. It is created by eHealthMe based on reports of 140,106 people who have side effects when taking Revlimid from FDA , and is updated regularly.

What to expect?

If you take Revlimid and have Shortness of breath, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Revlimid and have Shortness of breath

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 23, 2017

140,106 people reported to have side effects when taking Revlimid.
Among them, 3,474 people (2.48%) have Shortness of breath


Number of reports submitted per year:

Could Revlimid cause Shortness of breath?

Time on Revlimid when people have Shortness of breath *:

  • < 1 month: 50.61 %
  • 1 - 6 months: 36.05 %
  • 6 - 12 months: 8.16 %
  • 1 - 2 years: 3.64 %
  • 2 - 5 years: 1.54 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Shortness of breath when taking Revlimid *:

  • female: 46.2 %
  • male: 53.8 %

Age of people who have Shortness of breath when taking Revlimid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.15 %
  • 20-29: 0.35 %
  • 30-39: 0.89 %
  • 40-49: 3.75 %
  • 50-59: 14.19 %
  • 60+: 80.67 %

Top conditions involved for these people *:

  • Myelodysplastic Syndrome (307 people, 8.84%)
  • High Blood Pressure (111 people, 3.20%)
  • Pain (99 people, 2.85%)
  • Preventive Health Care (88 people, 2.53%)
  • Neoplasm Malignant (55 people, 1.58%)

Top co-used drugs for these people *:

  • Zometa (477 people, 13.73%)
  • Dexamethasone (390 people, 11.23%)
  • Velcade (362 people, 10.42%)
  • Aspirin (331 people, 9.53%)
  • Decadron (247 people, 7.11%)

Top other side effects for these people *:

  • Fatigue (862 people, 24.81%)
  • Weakness (514 people, 14.80%)
  • Anaemia (510 people, 14.68%)
  • Chest Pain (478 people, 13.76%)
  • Thrombocytopenia (470 people, 13.53%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Shortness of breath when taking Revlimid?

Expand the study to include all drugs with the same ingredients

Shortness of breath and drugs with ingredients of lenalidomide.

Expand the study to include reports from both FDA and eHealthMe

Shortness of breath and Revlimid from FDA and eHealthMe reports

Revlimid

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. (latest outcomes from Revlimid 140,337 users)

Shortness of breath

Shortness of breath has been reported by people with high blood pressure, chronic obstructive pulmonary disease, asthma, primary pulmonary hypertension, rheumatoid arthritis (latest reports from 313,725 Shortness of breath patients).

Browse all side effects of Revlimid

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Shortness of breath

Shortness of breath

Could your condition cause Shortness of breath

Shortness of breath

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Revlimid and have Shortness of breath.

Questions to the study

More questions >

User reviews to the study

More reviews >